Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Manitoba to expand its COVID-19 vaccine effort with large Moderna supply

06/16/2021 | 03:23pm EDT

WINNIPEG — The Manitoba government says it is set to achieve its long-stated goal of administering 20,000 COVID-19 vaccine doses per day.

Johanu Botha, co-lead of the province's vaccination team, says about 300,000 doses of Moderna vaccine are due to arrive by the end of the month, starting at the end of this week.

Along with a steady supply of the Pfizer-BioNTech vaccine, Manitoba is aiming to administer 175,000 doses next week — 70,000 more than this week.

Premier Brian Pallister has frequently said the province has the capacity to deliver 20,000 doses daily if supplies were strong enough.

Botha says the province could very well exceed that, due to record-high supplies, increased walk-in vaccinations and an expanded use of pharmacies and medical clinics.

Botha also said the province is aiming to have all Manitobans aged 12 and up eligible for a second dose by the end of next week.

Currently, Indigenous persons and people with certain underlying medical conditions can book second doses. For others, only people who received a first dose on or before May 14 are eligible.

"It's certainly not a hard, confirmed line in the sand. Our approach has always been to monitor ... but yeah, we're targeting end of next week," Botha said Wednesday.

The announcement came as health officials reported 144 new COVID-19 cases and seven deaths. It was the fourth consecutive day that new case counts were under 200.

The five-day percentage of people testing positive continued to drop, and sat at 9.7 per cent provincially and 9.2 per cent in Winnipeg.

This report by The Canadian Press was first published June 16, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about MODERNA, INC.
08/03MODERNA : U.S. administers 347.4 mln doses of COVID-19 vaccines - CDC
RE
08/03MODERNA : U.S. CDC Says Delivered 401,229,975 Doses Of Covid-19 Vaccine As Of Au..
RE
08/03MODERNA : Covid-19 3rd Wave - Federal Govt Declares Lagos, Akwa Ibom, Rivers, Ka..
AQ
08/03MODERNA : Respiratory Syncytial Virus Vaccine mRNA-1345 Receives FDA Fast-Track ..
MT
08/03Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
08/03MODERNA : Receives FDA Fast Track Designation for Respiratory Syncytial Virus (R..
BU
08/03Sanofi bets on mRNA vaccines beyond COVID in $3.2 billion Translate Bio deal
RE
08/03Moderna Gets FDA Fast Track Designation for Respiratory Syncytial Virus Vacci..
DJ
08/03ASTRAZENECA : Sanwo-Olu - Lagos Recorded 4,300 Cases, 30 Fatalities in July
AQ
08/03MODERNA : Covid-19 - U.S. Delivers 4m Doses Moderna Vaccines to Nigeria to Comba..
AQ
More news
Financials (USD)
Sales 2021 19 117 M - -
Net income 2021 10 725 M - -
Net cash 2021 11 948 M - -
P/E ratio 2021 15,3x
Yield 2021 -
Capitalization 155 B 155 B -
EV / Sales 2021 7,49x
EV / Sales 2022 8,47x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Last Close Price 386,51 $
Average target price 187,80 $
Spread / Average Target -51,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.269.97%155 195
LONZA GROUP AG25.60%58 688
IQVIA HOLDINGS INC.39.52%47 386
CELLTRION, INC.-26.18%31 285
SEAGEN INC.-9.68%28 062
PHARMARON BEIJING CO., LTD.82.70%24 138